Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab versus fumaric acid esters in moderate to severe plaque psoriasis
2010-018369-48Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Feb 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of adalimumab and dimethyl fumarate + ethyl hydrogen fumarate in plaque psoriasis (2 arms), sponsored by Medical University of Vienna. Started Feb 2011; status: completed.
02
Drugs
adalimumabdimethyl fumarate + ethyl hydrogen fumarate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2010-018369-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018369-48.